News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
56,400 Results
Type
Article (4960)
Company Profile (17)
Press Release (51421)
Multimedia
Podcasts (1)
Webinars (4)
Section
Business (17118)
Career Advice (264)
Deals (2655)
Drug Delivery (11)
Drug Development (2919)
Employer Resources (23)
FDA (1113)
Job Trends (1710)
News (24159)
Policy (2121)
Tag
Academia (564)
Allergies (3)
Alliances (5783)
ALS (12)
Alzheimer's disease (136)
Antibody-drug conjugate (ADC) (26)
Approvals (1128)
Artificial intelligence (127)
Autoimmune disease (13)
Automation (22)
Bankruptcy (24)
Best Places to Work (1178)
BIOSECURE Act (1)
Biosimilars (26)
Biotechnology (8)
Bladder cancer (3)
Brain cancer (4)
Breast cancer (35)
Cancer (326)
Cardiovascular disease (29)
Career advice (235)
Career pathing (12)
CAR-T (15)
CDC (2)
Cell therapy (50)
Cervical cancer (11)
Clinical research (2010)
Collaboration (236)
Compensation (8)
Complete response letters (1)
COVID-19 (436)
CRISPR (13)
C-suite (65)
Cystic fibrosis (9)
Data (322)
Denatured (1)
Depression (4)
Diabetes (16)
Diagnostics (1835)
Digital health (7)
Diversity (1)
Diversity, equity & inclusion (3)
Drug discovery (51)
Drug pricing (6)
Drug shortages (2)
Duchenne muscular dystrophy (3)
Earnings (4654)
Editorial (4)
Employer branding (2)
Employer resources (21)
Events (5956)
Executive appointments (89)
FDA (1287)
Friedreich's ataxia (2)
Frontotemporal dementia (3)
Funding (192)
Gene editing (22)
Generative AI (11)
Gene therapy (36)
GLP-1 (61)
Government (475)
Grass and pollen (1)
Guidances (24)
Healthcare (1532)
HIV (6)
Huntington's disease (2)
IgA nephropathy (2)
Immunology and inflammation (15)
Immuno-oncology (4)
Indications (3)
Infectious disease (473)
Inflammatory bowel disease (15)
Influenza (33)
Intellectual property (11)
Interviews (34)
IPO (905)
IRA (4)
Job creations (525)
Job search strategy (199)
JPM (11)
Labor market (20)
Layoffs (44)
Leadership (15)
Legal (354)
Liver cancer (2)
Longevity (4)
Lung cancer (33)
Lymphoma (26)
Machine learning (15)
Management (5)
Manufacturing (108)
MASH (2)
Medical device (1017)
Medtech (1022)
Mergers & acquisitions (1844)
Metabolic disorders (46)
Multiple sclerosis (6)
Neurodegenerative disease (23)
Neuropsychiatric disorders (3)
Neuroscience (227)
Neurotech (1)
NextGen: Class of 2026 (716)
Non-profit (549)
Now hiring (19)
Obesity (27)
Opinion (58)
Ovarian cancer (10)
Pain (8)
Pancreatic cancer (13)
Parkinson's disease (25)
Partnered (9)
Patents (19)
Patient recruitment (16)
Peanut (3)
People (4888)
Pharmaceutical (2)
Phase 1 (727)
Phase 2 (892)
Phase 3 (693)
Pipeline (451)
Policy (13)
Postmarket research (92)
Preclinical (514)
Press Release (18)
Prostate cancer (21)
Psychedelics (5)
Radiopharmaceuticals (13)
Rare diseases (39)
Real estate (1446)
Recruiting (13)
Regulatory (1564)
Reports (11)
Research institute (534)
Resumes & cover letters (31)
Rett syndrome (3)
RNA editing (1)
RSV (6)
Schizophrenia (7)
Series A (35)
Series B (22)
Service/supplier (2)
Sickle cell disease (2)
Special edition (3)
Spinal muscular atrophy (5)
Sponsored (8)
Startups (506)
Stomach cancer (1)
Supply chain (11)
Tariffs (4)
Vaccines (48)
Venture capital (19)
Weight loss (15)
Women's health (10)
Worklife (5)
Date
Today (10)
Last 7 days (45)
Last 30 days (164)
Last 365 days (2208)
2026 (247)
2025 (2210)
2024 (2722)
2023 (3294)
2022 (4753)
2021 (5005)
2020 (5653)
2019 (4220)
2018 (3032)
2017 (2947)
2016 (3152)
2015 (3175)
2014 (2191)
2013 (1943)
2012 (2074)
2011 (2186)
2010 (1618)
Location
Africa (109)
Alabama (10)
Alaska (1)
Arizona (28)
Arkansas (1)
Asia (3162)
Australia (420)
California (799)
Canada (234)
China (80)
Colorado (38)
Connecticut (96)
Delaware (15)
Europe (6300)
Florida (62)
Georgia (26)
Idaho (5)
Illinois (56)
India (13)
Indiana (62)
Iowa (7)
Japan (24)
Kansas (6)
Kentucky (3)
Louisiana (3)
Maine (6)
Maryland (87)
Massachusetts (567)
Michigan (87)
Minnesota (44)
Mississippi (1)
Missouri (29)
Montana (5)
Nebraska (5)
Nevada (10)
New Hampshire (9)
New Jersey (176)
New Mexico (11)
New York (233)
North Carolina (118)
North Dakota (3)
Northern California (388)
Ohio (62)
Oklahoma (3)
Oregon (8)
Pennsylvania (160)
Rhode Island (3)
South America (191)
South Carolina (8)
Southern California (282)
Tennessee (41)
Texas (133)
United States (3033)
Utah (53)
Virginia (19)
Washington D.C. (4)
Washington State (77)
West Virginia (2)
Wisconsin (22)
56,400 Results for "calico labs".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Layoffs
AbbVie Ends 11-Year Relationship With Calico, Lays Off 100+
In January, AbbVie and Calico’s fosigotifator failed to show significant signs of efficacy in the HEALEY ALS platform trial for amyotrophic lateral sclerosis.
November 13, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Calico Appoints Joseph R. Arron, M.D., Ph.D., as Head of Human Biology and Genetics
February 5, 2026
·
3 min read
Collaboration
Alphabet Subsidiary Calico Colors In Up To $570M+ Aging Deal With China’s Mabwell
Calico will leverage 9MW3811’s anti-inflammatory mechanism to advance its mission of addressing aging-related diseases.
June 27, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Calico Appoints Philip R. Kym, Ph.D., as Head of Drug Discovery
October 17, 2025
·
3 min read
Press Releases
Calico Life Sciences Announces U.S. FDA Orphan Drug Designation for Investigational Treatment of Autosomal Dominant Polycystic Kidney Disease
November 6, 2025
·
2 min read
Press Releases
Calico Life Sciences Announces U.S. FDA Fast Track Designation for Investigational Treatment of Autosomal Dominant Polycystic Kidney Disease
October 3, 2025
·
2 min read
ALS
HEALEY ALS Trial Serves Up More Disappointment as Denali, AbbVie/Calico Fail
Misses from amyotrophic lateral sclerosis hopefuls Denali Therapeutics and partners AbbVie and Calico Life Sciences mark the latest setbacks for the controversial platform trial, the results from which have largely mirrored the dismal success rate in ALS overall.
January 10, 2025
·
5 min read
·
Heather McKenzie
Press Releases
EVQLV Launches Abtique, the First Marketplace for AI-Designed Molecules Validated in Independent Labs
New “click-to-sequence” platform lets researchers buy AI-designed antibody sequences online, using an AI system that learns from real lab results
November 20, 2025
·
1 min read
Biotech Bay
Calico Life Sciences Announces that Fosigotifator (ABBV-CLS-7262) for Vanishing White Matter Disease has been Selected for the FDA START Pilot Program
Calico Life Sciences LLC today announced that its investigational eIF2B activator fosigotifator (ABBV-CLS-7262) has been accepted into the U.S. Food and Drug Administration (FDA) Support for clinical Trials Advancing Rare disease Therapeutics (START) Pilot Program.
June 7, 2024
·
3 min read
Press Releases
Unchained Labs Cracks the Code on ADC Characterization
January 6, 2026
·
1 min read
1 of 5,640
Next
